CSL Behring UK Limited

Hayworth House, Market Place, Haywards Heath, West Sussex, RH16 1DB, UK
Telephone: +44 (0)1444 447 400
Fax: +44 (0)1444 447 403
WWW: http://www.cslbehring.co.uk
Medical Information Direct Line: +44 (0)1444 447 405
Medical Information e-mail: medinfo@cslbehring.com
Customer Care direct line: +44 (0)1444 447 402
Out of Hours contact: +44 (0)1444 447 405

Patient Information Leaflet last updated on the eMC: 12/08/2011
PIL Rhophylac 300 (1500 IU)

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 28/07/2010 and displayed until 12/08/2011
Reasons for adding or updating:
  • Addition of separate PILs covering individual presentations
Updated on 12/11/2009 and displayed until 28/07/2010
Reasons for adding or updating:
  • Removal/change of distributor
Updated on 13/06/2008 and displayed until 12/11/2009
Reasons for adding or updating:
  • Company name change or merger
  • Change to date of revision
Updated on 09/11/2006 and displayed until 13/06/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 23/06/2006 and displayed until 09/11/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   human anti-d immunoglobulin